Effect of rapid-acting insulin Lispro® on brittle diabetes

被引：0
|
作者：
Juang, JH
Wu, WP
机构：
来源：
DIABETES | 2001年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A439 / A439
页数：1
相关论文
共 50 条
  • [1] Usefulness of rapid-acting insulin lispro in CSII
    Yanagisawa, K
    Tuchida, KI
    Endo, M
    Masuda, H
    Makita, Z
    Koike, T
    DIABETES, 2001, 50 : A446 - A446
  • [2] A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes
    Bramlage, Peter
    Tittel, Sascha R.
    Muether, Silvia
    Reinhart-Steininger, Birgit
    Haberland, Holger
    Khodaverdi, Semik
    Zimny, Stefan
    Ohlenschlaeger, Ute
    Lanzinger, Stefanie
    Haak, Thomas
    ACTA DIABETOLOGICA, 2022, 59 (11) : 1453 - 1460
  • [3] Insulin lispro (Humalog®, rDNA origin), a rapid-acting mealtime human insulin analog.
    Anderson, JH
    Chance, RE
    DiMarchi, RD
    Frank, BH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U892 - U892
  • [4] A comparison of the rapid-acting insulin analogue glulisine with lispro and aspart for the pump treatment of patients with type 1 diabetes
    Peter Bramlage
    Sascha R. Tittel
    Silvia Müther
    Birgit Reinhart-Steininger
    Holger Haberland
    Semik Khodaverdi
    Stefan Zimny
    Ute Ohlenschläger
    Stefanie Lanzinger
    Thomas Haak
    Acta Diabetologica, 2022, 59 : 1453 - 1460
  • [5] Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
    Garg, SK
    Ellis, SL
    Ulrich, H
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 643 - 651
  • [6] Rapid-Acting Insulin Analogs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1327): : 98 - 98
  • [7] The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes
    Gallagher, A.
    Butler, T. J.
    Home, P. D.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (03) : 327 - 334
  • [8] CONCENTRATED RAPID-ACTING INSULIN PREPARATIONS
    Handeslman, Yehuda
    ENDOCRINE PRACTICE, 2017, 23 : 18 - 23
  • [9] Flexibility of rapid-acting insulin analogues in children and adolescents with diabetes mellitus
    Danne, Thomas
    CLINICAL THERAPEUTICS, 2007, 29 : S145 - S152
  • [10] Technosphere insulin suppresses endogenous glucose production earlier than a rapid-acting analogue (lispro) and an inhaled insulin (Exubera®)
    Potocka, E.
    Hovorka, R.
    Baughman, R.
    Umpleby, M.
    Diaz, M.
    Chen, R.
    Cassidy, J.
    Boss, A.
    Richardson, P.
    DIABETOLOGIA, 2009, 52 : S374 - S374
12345